Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
Contact Us |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages
Start Over | Back to Search Results
Etomidate Injection
Status: Currently in Shortage
»Date first posted:
10/05/2022
»Therapeutic Categories: Anesthesiology
Avet Pharmaceuticals, Inc. (Revised 12/22/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 20 mg/10mL carton of 10 (NDC 23155-160-41) | Product available upon request | ||
| 40 mg/20 mL carton of 10 (NDC 23155-160-42) | Product available upon request |
Caplin Steriles, Ltd. (Revised 01/26/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 20 mg per 10 mL, Single dose vial, (NDC 65219-445-10) | 1 month expiry (2/28/2023 expiry) dating available by request. | Marketed by Fresenius Kabi; Check wholesalers for inventory
Fresenius Kabi Etomidate Shelf Life Extension Letter Search List of Extended Use Dates to Assist with Drug Shortages |
|
| 40 mg per 20 mL, Single dose vial, (NDC 65219-445-20) | 1 month expiry (2/28/2023 expiry) dating available by request. | Marketed by Fresenius Kabi
Fresenius Kabi Etomidate Shelf Life Extension Letter Search List of Extended Use Dates to Assist with Drug Shortages |
|
| 2 mg/mL, 10 mL vial (NDC 25021-674-10) | Available | Marketed by Sagent | |
| 2 mg/mL, 20 mL vial (NDC 25021-674-20) | Available | Marketed by Sagent |
Eugia US, LLC (formerly AuroMedics Pharma LLC) [mfd. by Eugia Pharma Specialties, Ltd.) (Revised 01/24/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 2 mg/mL, 10 mL vial (NDC 55150-221-10) | Currently on backorder - next shipment February 2023 | Check wholesalers for inventory | Other |
| 2 mg/mL, 20 mL vial (NDC 55150-222-20) | Currently on backorder - next shipment February 2023 | Other |
Gland Pharma Limited (New 10/05/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 2 mg/mL, 10 mL vial (NDC 72266-146-10) | Pending information | Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. | |
| 2 mg/mL, 20 mL vial (NDC 72266-147-10) | Pending information | Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. |
Hikma Pharmaceuticals, LLC (formerly West-Ward) (New 10/05/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 2 mg/mL, 10 mL vial (NDC 0143-9506-10) | Currently on backorder | Demand increase for the drug | |
| 2 mg/mL, 20 mL vial (NDC 0143-9507-10) | Currently on backorder | Demand increase for the drug | |
| 2 mg/mL, 10 mL vial (NDC 0143-9310-10), Novaplus | Pending information | ||
| 2 mg/mL, 20 mL vial (NDC 0143-9311-10), Novaplus | Pending information | ||
| 2 mg/mL, 10 mL vial (NDC 72572-160-10) | Pending information | Distributed by Civica | |
| 2 mg/mL, 20 mL vial (NDC 72572-161-10) | Pending information | Distributed by Civica |
Hospira, Inc., a Pfizer Company (Reverified 01/20/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Amidate, 2 mg/mL, 10 mL vial (NDC 0409-6695-01) | Next Delivery: May 2023; Estimated recovery: June 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| Amidate, 2 mg/mL, 20 mL vial (NDC 0409-6695-02) | Next Delivery and Estimated Recovery: June 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
Mylan Pharmaceuticals Inc., a Viatris Company (Reverified 01/31/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 2 mg/mL, 10 mL vial (NDC 67457-902-10) | Q1 2023 | Demand increase for the drug | |
| 2 mg/mL, 20 mL vial (NDC 67457-903-20) | Q1 2023 | Demand increase for the drug |